Molnupiravir not included in COVID-19 treatment guidelines as its harms outweigh benefits : Health Ministry The Ministry said that after trials and discussions it has been found that Molnupiravir was not of much benefit in COVID treatment since the drug has risks and warrants caution in use and efforts should be made to restrict its use as the known and unknown harms far outweigh its claimed benefits.